» Articles » PMID: 35429984

Mean Generation Function Model in AIDS Epidemic Estimation

Overview
Publisher Biomed Central
Date 2022 Apr 17
PMID 35429984
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Since the first case of HIV infection was reported in China in 1985, the incidence and mortality of AIDS have been increasing rapidly, which has caused serious damage to the life and health of people in China and all over the world. Therefore, it is of great significance to study the technique for predicting AIDS morbidity and mortality. The purpose of this research is to explore the applicability of the mean generation function model (MGFM) in the early warning of AIDS morbidity and mortality, to predict its prevalence trend, to enrich the prediction techniques and methods of AIDS research and to provide suggestions for AIDS transmission control.

Methods: In this research, the MGFM was applied to predict the incidence and mortality of AIDS in China. AIDS incidence and mortality data in China from 2008 to 2019 were used to construct the prediction model.

Results: The MGFM can predict the annual incidence and mortality of AIDS. The model constructed in this research predicted that the incidence and mortality of AIDS in China will continue to increase from 2020 to 2023.

Conclusion: The mean birth function model was an effective method to monitor and predict the changing trend of AIDS incidence and mortality in China.

References
1.
Barr L, Jefferys R . A landscape analysis of HIV cure-related clinical research in 2019. J Virus Erad. 2020; 6(4):100010. PMC: 7695817. DOI: 10.1016/j.jve.2020.100010. View

2.
Huang M, Ye L, Liang B, Ning C, Roth W, Jiang J . Characterizing the HIV/AIDS Epidemic in the United States and China. Int J Environ Res Public Health. 2015; 13(1):ijerph13010030. PMC: 4730421. DOI: 10.3390/ijerph13010030. View

3.
Chen F, Guo W, Qin Q, Cai C, Cui Y . [Spatial-temporal distribution of newly detected HIV/AIDS cases among aged 15 years or older women in China, 2010-2016]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018; 39(6):739-744. DOI: 10.3760/cma.j.issn.0254-6450.2018.06.009. View

4.
Bhatt M, Soneja M, Gupta N . COVID-19 in patients living with human immunodeficiency virus (HIV) infection: Challenges and way-forward. Drug Discov Ther. 2021; 15(1):42-43. DOI: 10.5582/ddt.2020.03111. View

5.
Ogunbodede O, Zablotska-Manos I, Lewis D . Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections: Republication. Curr Opin HIV AIDS. 2021; 16(2):115-120. DOI: 10.1097/COH.0000000000000672. View